| Indicators | Browse All

MDxHealth SA (MDXH)

Healthcare | Diagnostics & Research | Herstal, Belgium | NasdaqCM
0.22 USD -0.38 (-63.552%) ⇩ (Oct. 16, 2026, 12:33 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 11:28 a.m. EDT

The immediate outlook is severely compromised by a catastrophic breakdown in the company's financial reporting infrastructure, evidenced by a beta value of -518,287 and a book value of -$0.59, which renders standard valuation metrics like P/E and P/B meaningless. While the price has recently recovered from a 57% drop in 2023 to a 104% surge in 2025, the current trajectory shows the stock trading significantly below its 200-day average, suggesting lingering weakness. More critically, the business is hemorrhaging cash with negative operating and free cash flows, and the board has cut the dividend entirely, signaling a lack of capital to return to shareholders. With analysts warning of a Nasdaq delisting due to market cap rules and disputes over Medicare reimbursement, the fundamental uncertainty is too high to justify a bullish stance, despite the low absolute share price.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.368163
AutoARIMA0.369351
MSTL0.372320
AutoTheta0.427184

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 17%
H-stat 0.40
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 16.31
Attribute Value
Sector Healthcare
Revenue per Share 2.265
Market Cap 20,991,824
Forward P/E -0.58
Beta -518287.38
Profit Margins -32.74%
Website https://mdxhealth.com

Info Dump

Attribute Value
52 Week Change -0.84937656
Address1 CAP Business Center
Address2 Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts
All Time High 13.17
All Time Low 0.35
Ask 2.0
Ask Size 42
Audit Risk 4
Average Daily Volume10 Day 260,570
Average Daily Volume3 Month 5,680,487
Average Volume 5,680,487
Average Volume10Days 260,570
Beta -518,287.38
Bid 0.5958
Bid Size 1
Board Risk 6
Book Value -0.592
City Herstal
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 10
Country Belgium
Crypto Tradeable 0
Currency USD
Current Price 0.22
Current Ratio 1.15
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.41
Day Low 0.2145
Display Name MDxHealth
Dividend Yield 0.0
Earnings Call Timestamp End 1,786,653,000
Earnings Call Timestamp Start 1,786,653,000
Earnings Timestamp 1,786,651,200
Earnings Timestamp End 1,794,513,600
Earnings Timestamp Start 1,794,513,600
Ebitda -14,928,000
Ebitda Margins -0.13092
Enterprise To Ebitda -7.881
Enterprise To Revenue 1.032
Enterprise Value 117,642,624
Eps Current Year -0.46
Eps Forward -0.38
Eps Trailing Twelve Months -0.7
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.64174
Fifty Day Average Change -0.42174003
Fifty Day Average Change Percent -0.65718204
Fifty Two Week Change Percent -84.93765
Fifty Two Week High 5.33
Fifty Two Week High Change -5.11
Fifty Two Week High Change Percent -0.95872426
Fifty Two Week Low 0.2145
Fifty Two Week Low Change 0.0055000037
Fifty Two Week Low Change Percent 0.025641043
Fifty Two Week Range 0.2145 - 5.33
Financial Currency USD
First Trade Date Milliseconds 1,636,032,600,000
Float Shares 42,511,845
Forward Eps -0.38
Forward P E -0.57894737
Free Cashflow -17,405,124
Full Exchange Name NasdaqCM
Full Time Employees 364
Fullday Change -0.38360003
Fullday Change Percent -63.552025
Fullday Price 0.22
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.62858003
Gross Profits 71,673,000
Has Pre Post Market Data 1
Held Percent Insiders 0.2214
Held Percent Institutions 0.45152
Implied Shares Outstanding 95,417,382
Industry Diagnostics & Research
Industry Disp Diagnostics & Research
Industry Key diagnostics-research
Ipo Expected Date 2,021-11-04
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Long Name MDxHealth SA
Market us_market
Market Cap 20,991,824
Market State REGULAR
Max Age 86,400
Message Board Id finmb_4803148
Most Recent Quarter 1,782,777,600
Net Income To Common -36,431,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 57,240,887
Number Of Analyst Opinions 5
Open 0.4
Operating Cashflow -5,300,000
Operating Margins -0.1874
Overall Risk 8
Phone 866 259 5644
Previous Close 0.6036
Price Eps Current Year -0.47826084
Price Hint 4
Price To Book -0.3716216
Price To Sales Trailing12 Months 0.18410005
Profit Margins -0.32744998
Quick Ratio 0.913
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.38360003
Regular Market Change Percent -63.552025
Regular Market Day High 0.41
Regular Market Day Low 0.2145
Regular Market Day Range 0.2145 - 0.41
Regular Market Open 0.4
Regular Market Previous Close 0.6036
Regular Market Price 0.22
Regular Market Time 1,792,168,415
Regular Market Volume 9,587,705
Return On Assets -0.09834
Revenue Growth 0.023
Revenue Per Share 2.265
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 4
Shares Outstanding 95,417,382
Shares Percent Shares Out 0.014099999
Shares Short 1,343,795
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 1,535,517
Short Name MDxHealth SA
Short Percent Of Float 0.0162
Short Ratio 5.92
Source Interval 15
Symbol MDXH
Target High Price 3.0
Target Low Price 1.0
Target Mean Price 1.8
Target Median Price 2.0
Total Cash 19,207,000
Total Cash Per Share 0.374
Total Debt 105,846,000
Total Revenue 114,024,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.7
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.702765
Two Hundred Day Average Change -1.482765
Two Hundred Day Average Change Percent -0.87079835
Type Disp Equity
Volume 9,587,705
Website https://mdxhealth.com
Zip 4,040